NEUROPROTECTIVE POTENTIAL Emerging research highlights the potential neuroprotective effects of the peptide BPC-157
While animal studies show a good safety profile, a theoretical risk involving its pro-angiogenic effects and potential cancer promotion is a point of consideration, though no evidence has supported this risk in practice
Best Quality ProductsMedicinesPillsHerbs at best prices
For detailed information on what BPC-157 is and how it was discovered, that guide provides thorough background
GPs can prescribe B12 injections following appropriate investigation, which should include: Full blood count to identify macrocytic anaemia Serum B12 and folate levels to confirm deficiency (using laboratory-specific reference ranges) Methylmalonic acid and/or homocysteine when B12 results are borderline Intrinsic factor antibodies if pernicious anaemia is suspected Additional tests depending on clinical presentation (e.g., thyroid function, coeliac serology) When both B12 and folate deficiency are present, B12 should be replaced before folate to avoid precipitating subacute combined degeneration of the spinal cord
Safety-first, evidence-forward guidance for GLP-1s
